Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2004 Aug;13(4):285–291. doi: 10.1080/09629350400003118

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.

Ilknur Basyigit 1, Fusun Yildiz 1, Sevgiye Kacar Ozkara 1, Hasim Boyaci 1, Ahmet Ilgazli 1
PMCID: PMC1781566  PMID: 15545060

Abstract

AIM: To determine induced sputum cell counts and interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-alpha) and leukotriene B4 (LTB4) levels as markers of neutrophilic inflammation in moderate persistent asthma, and to evaluate the response to inhaled steroid therapy. METHODS: Forty-five moderate asthmatic patients and 10 non-smoker controls were included in this study. All patients received inhaled corticosteroid (800 microg of budesonide) for 12 weeks. Before and after treatment pulmonary function tests were performed, and symptom scores were determined. Blood was drawn for analysis of serum inflammatory markers, and sputum was induced. RESULTS: Induced sputum cell counts and inflammatory markers were significantly higher in patients with asthma than in the control group. The induced sputum eosinophil counts of 12 patients (26%) were found to be less than 5%, the non-eosinophilic group, and sputum neutrophil counts, IL-8 and TNF-alpha levels were significantly higher than the eosinophilic group (neutrophil, 50+/-14% versus 19+/-10%, p<0.01). In both groups, there was a significant decrease in sputum total cell counts and serum and sputum IL-8, TNF-alpha and LTB4 levels after the treatment. There was no change in sputum neutrophil counts. Although the sputum eosinophil count decreased only in the eosinophilic subjects, there was no significant difference in inflammatory markers between the groups. The symptom scores were significantly improved after treatment, while the improvement did not reach statistical significance on pulmonary function test parameters. CONCLUSION: Notably, in chronic asthma there is a subgroup of patients whose predominant inflammatory cells are not eosinophils. Sputum neutrophil counts and neutrophilic inflammatory markers are significantly higher in these patients. In the non-eosinophilic group, inhaled steroid caused an important decrease in inflammatory markers; however, there was no change in the sputum eosinophil and neutrophil counts.

Full Text

The Full Text of this article is available as a PDF (103.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beeh Kai M., Kornmann Oliver, Buhl Roland, Culpitt Sarah V., Giembycz Mark A., Barnes Peter J. Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. Chest. 2003 Apr;123(4):1240–1247. doi: 10.1378/chest.123.4.1240. [DOI] [PubMed] [Google Scholar]
  2. Chalmers G. W., MacLeod K. J., Thomson L., Little S. A., McSharry C., Thomson N. C. Smoking and airway inflammation in patients with mild asthma. Chest. 2001 Dec;120(6):1917–1922. doi: 10.1378/chest.120.6.1917. [DOI] [PubMed] [Google Scholar]
  3. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol. 1995 May 1;154(9):4719–4725. [PubMed] [Google Scholar]
  4. Diamant Z., Grootendorst D. C., Veselic-Charvat M., Timmers M. C., De Smet M., Leff J. A., Seidenberg B. C., Zwinderman A. H., Peszek I., Sterk P. J. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy. 1999 Jan;29(1):42–51. doi: 10.1046/j.1365-2222.1999.00447.x. [DOI] [PubMed] [Google Scholar]
  5. Douwes J., Gibson P., Pekkanen J., Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002 Jul;57(7):643–648. doi: 10.1136/thorax.57.7.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fahy J. V., Kim K. W., Liu J., Boushey H. A. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995 Apr;95(4):843–852. doi: 10.1016/s0091-6749(95)70128-1. [DOI] [PubMed] [Google Scholar]
  7. Gibson P. G., Simpson J. L., Saltos N. Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 2001 May;119(5):1329–1336. doi: 10.1378/chest.119.5.1329. [DOI] [PubMed] [Google Scholar]
  8. Godon P., Boulet L. P., Malo J. L., Cartier A., Lemière C. Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids. Eur Respir J. 2002 Dec;20(6):1364–1369. doi: 10.1183/09031936.02.00017502. [DOI] [PubMed] [Google Scholar]
  9. Green R. H., Brightling C. E., Woltmann G., Parker D., Wardlaw A. J., Pavord I. D. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax. 2002 Oct;57(10):875–879. doi: 10.1136/thorax.57.10.875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Inoue H., Aizawa H., Fukuyama S., Takata S., Matsumoto K., Shigyo M., Koto H., Hara N. Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients. Lung. 1999;177(1):53–62. doi: 10.1007/pl00007627. [DOI] [PubMed] [Google Scholar]
  11. Jatakanon A., Lim S., Chung K. F., Barnes P. J. An inhaled steroid improves markers of airway inflammation in patients with mild asthma. Eur Respir J. 1998 Nov;12(5):1084–1088. doi: 10.1183/09031936.98.12051084. [DOI] [PubMed] [Google Scholar]
  12. Jatakanon A., Uasuf C., Maziak W., Lim S., Chung K. F., Barnes P. J. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1532–1539. doi: 10.1164/ajrccm.160.5.9806170. [DOI] [PubMed] [Google Scholar]
  13. Jung K. S., Park H. S. Evidence for neutrophil activation in occupational asthma. Respirology. 1999 Sep;4(3):303–306. doi: 10.1046/j.1440-1843.1999.00196.x. [DOI] [PubMed] [Google Scholar]
  14. Keatings V. M., Collins P. D., Scott D. M., Barnes P. J. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med. 1996 Feb;153(2):530–534. doi: 10.1164/ajrccm.153.2.8564092. [DOI] [PubMed] [Google Scholar]
  15. Louis R., Lau L. C., Bron A. O., Roldaan A. C., Radermecker M., Djukanović R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 2000 Jan;161(1):9–16. doi: 10.1164/ajrccm.161.1.9802048. [DOI] [PubMed] [Google Scholar]
  16. Montuschi Paolo, Barnes Peter J. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol. 2002 Apr;109(4):615–620. doi: 10.1067/mai.2002.122461. [DOI] [PubMed] [Google Scholar]
  17. Obase Y., Shimoda T., Mitsuta K., Matsuo N., Matsuse H., Kohno S. Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum. Ann Allergy Asthma Immunol. 2001 Mar;86(3):304–310. doi: 10.1016/S1081-1206(10)63303-0. [DOI] [PubMed] [Google Scholar]
  18. Pavord I. D., Brightling C. E., Woltmann G., Wardlaw A. J. Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 1999 Jun 26;353(9171):2213–2214. doi: 10.1016/S0140-6736(99)01813-9. [DOI] [PubMed] [Google Scholar]
  19. Pavord I. D., Ward R., Woltmann G., Wardlaw A. J., Sheller J. R., Dworski R. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med. 1999 Dec;160(6):1905–1909. doi: 10.1164/ajrccm.160.6.9903114. [DOI] [PubMed] [Google Scholar]
  20. Pin I., Gibson P. G., Kolendowicz R., Girgis-Gabardo A., Denburg J. A., Hargreave F. E., Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992 Jan;47(1):25–29. doi: 10.1136/thx.47.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Popov T., Gottschalk R., Kolendowicz R., Dolovich J., Powers P., Hargreave F. E. The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy. 1994 Aug;24(8):778–783. doi: 10.1111/j.1365-2222.1994.tb00990.x. [DOI] [PubMed] [Google Scholar]
  22. Seggev J. S., Thornton W. H., Jr, Edes T. E. Serum leukotriene B4 levels in patients with obstructive pulmonary disease. Chest. 1991 Feb;99(2):289–291. doi: 10.1378/chest.99.2.289. [DOI] [PubMed] [Google Scholar]
  23. Sur S., Crotty T. B., Kephart G. M., Hyma B. A., Colby T. V., Reed C. E., Hunt L. W., Gleich G. J. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis. 1993 Sep;148(3):713–719. doi: 10.1164/ajrccm/148.3.713. [DOI] [PubMed] [Google Scholar]
  24. Thomas P. S. Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma. Immunol Cell Biol. 2001 Apr;79(2):132–140. doi: 10.1046/j.1440-1711.2001.00980.x. [DOI] [PubMed] [Google Scholar]
  25. Turner M. O., Hussack P., Sears M. R., Dolovich J., Hargreave F. E. Exacerbations of asthma without sputum eosinophilia. Thorax. 1995 Oct;50(10):1057–1061. doi: 10.1136/thx.50.10.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wenzel S. E., Schwartz L. B., Langmack E. L., Halliday J. L., Trudeau J. B., Gibbs R. L., Chu H. W. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999 Sep;160(3):1001–1008. doi: 10.1164/ajrccm.160.3.9812110. [DOI] [PubMed] [Google Scholar]
  27. Yamamoto C., Yoneda T., Yoshikawa M., Fu A., Tokuyama T., Tsukaguchi K., Narita N. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest. 1997 Aug;112(2):505–510. doi: 10.1378/chest.112.2.505. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES